Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #52300
advertisement
Cheng Y
32
Showing records 1 to 25 |
Display all abstracts from
Cheng Y
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Li Z
BMJ open ophthalmology
2025; 10:
126950
An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients
Fu X
Journal of chromatography. A
2025; 1750: 465939
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Zhang D
Experimental Eye Research
2025; 255: 110352
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
Fu X
Science progress
2025; 108: 368504241301520
126950
An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients
Guo W
Journal of chromatography. A
2025; 1750: 465939
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Hu F
Experimental Eye Research
2025; 255: 110352
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
He J
Science progress
2025; 108: 368504241301520
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Dai C
BMJ open ophthalmology
2025; 10:
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Li T
Experimental Eye Research
2025; 255: 110352
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
Li G
Science progress
2025; 108: 368504241301520
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Fan SJ
BMJ open ophthalmology
2025; 10:
126950
An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients
Cheng Y
Journal of chromatography. A
2025; 1750: 465939
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Tang G
BMJ open ophthalmology
2025; 10:
126950
An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients
Li L
Journal of chromatography. A
2025; 1750: 465939
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Liu H
Experimental Eye Research
2025; 255: 110352
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
Luo H
Science progress
2025; 108: 368504241301520
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Li Q
Experimental Eye Research
2025; 255: 110352
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
Peng R
Science progress
2025; 108: 368504241301520
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Liu C
BMJ open ophthalmology
2025; 10:
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Cheng Y
Experimental Eye Research
2025; 255: 110352
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
Cheng Y
Science progress
2025; 108: 368504241301520
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Qu B
BMJ open ophthalmology
2025; 10:
126135
Ahmed glaucoma valve implant for refractory glaucoma in children: A systematic review and meta-analysis
Peng J
Science progress
2025; 108: 368504241301520
126573
Trabeculectomy versus stepwise treatment for breaking the attack of acute primary angle closure in patients with long attack duration: study design and protocol for a multicentre randomised controlled trial (LAAAC)
Chang X
BMJ open ophthalmology
2025; 10:
126623
Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity
Zhang X; Xu P
Experimental Eye Research
2025; 255: 110352
«
1
2
»
Issue
25-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept